Velan Capital Investment Management LP Lantheus Holdings, Inc. Transaction History

Velan Capital Investment Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $1.51 Million - $2.27 Million	-25,000 Reduced 25.0%	75,000 $5.21 Million
Q2 2023 Aug 11, 2023	SELL	$82.41 - $99.65 $4.12 Million - $4.98 Million	-50,000 Reduced 33.33%	100,000 $8.39 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $2.44 Million - $3.88 Million	-50,000 Reduced 25.0%	150,000 $7.64 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $4.22 Million - $5.92 Million	-68,658 Reduced 25.56%	200,000 $14.1 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $2.85 Million - $3.73 Million	-51,342 Reduced 16.04%	268,658 $17.7 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $7.33 Million - $17.1 Million	-301,753 Reduced 48.53%	320,000 $17.7 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $14 Million - $18.9 Million	621,753 New	621,753 $18 Million

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

Stay updated on Velan Capital Investment Management LP with notifications on news.